EUVIMEDEUVIMED entdecken
Crossref

Higher objective responses by hepatic arterial infusion chemotherapy following atezolizumab and bevacizumab failure than when used as initial therapy in hepatocellular carcinoma: a retrospective study

Jae-Sung Yoo, Ji Hoon Kim, Hee Sun Cho, Ji Won Han, Jeong Won Jang, Jong Young Choi, Seung Kew Yoon, Suho Kim, Jung Suk Oh, Ho Jong Chun, Pil Soo Sung iD

Abdominal Radiology · 2024

DOI: 10.1007/s00261-024-04308-6 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Abdominal Radiology, 2024. Verfasst von Jae-Sung Yoo und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Hepatology, Seoul St Mary's Hospital, The Catholic University of Korea, 222, Banpo-daero, Seocho-gu, Seuol, 06591,…. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Bevacizumab, Infusions, Intra-Arterial. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: National Research Foundation of Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsBevacizumabInfusions, Intra-ArterialAntibodies, Monoclonal, HumanizedAntineoplastic Combined Chemotherapy ProtocolsHumansRetrospective StudiesMaleFemaleMiddle AgedAgedTreatment FailureHepatic ArteryAdultAged, 80 and over

Stichwörter der Autor:innen

Atezolizumab–bevacizumabHepatic artery infusion chemotherapyHepatocellular carcinomaObjective response rateSequential immuno-chemotherapy

Substanzen

BevacizumabAntibodies, Monoclonal, Humanizedatezolizumab

Autor:innen und Institutionen

  • Department of Gastroenterology and Hepatology, Seoul St Mary's Hospital, The Catholic University of Korea, 222, Banpo-daero, Seocho-gu, Seuol, 06591, Republic of Korea.
  • Department of Internal Medicine, Yeungnam University Medical Center, 170, Hyeonchung-ro, Nam-gu, Daegu, 42415, Republic of Korea.
  • Department of Gastroenterology and Hepatology, Uijeongbu St Mary's Hospital, The Catholic University of Korea, 271, Cheonbo-ro, Uijeongbu-si, Gyeonggi, 11765, Republic of Korea.
  • Department of Radiology, Seoul St Mary's Hospital, The Catholic University of Korea, 222, Banpo-daero, Seocho-gu, Seoul, 06591, Republic of Korea.
  • Department of Gastroenterology and Hepatology, Seoul St Mary's Hospital, The Catholic University of Korea, 222, Banpo-daero, Seocho-gu, Seuol, 06591, Republic of Korea. pssung@catholic.ac.kr.

ORCID-Profile: Pil Soo Sung

Förderung

  • National Research Foundation of Korea

Zitieren

APA

Yoo, J. S., Kim, J. H., Cho, H. S., Han, J. W., Jang, J. W., Choi, J. Y., Yoon, S. K., Kim, S., Oh, J. S., Chun, H. J., & Sung, P. S. (2024). Higher objective responses by hepatic arterial infusion chemotherapy following atezolizumab and bevacizumab failure than when used as initial therapy in hepatocellular carcinoma: a retrospective study. Abdominal Radiology. https://doi.org/10.1007/s00261-024-04308-6

Vancouver

Yoo JS, Kim JH, Cho HS, Han JW, Jang JW, Choi JY, et al. Higher objective responses by hepatic arterial infusion chemotherapy following atezolizumab and bevacizumab failure than when used as initial therapy in hepatocellular carcinoma: a retrospective study. Abdominal Radiology. 2024. doi:10.1007/s00261-024-04308-6

BibTeX
@article{Yoo2024,
  author = {Yoo, Jae-Sung and Kim, Ji Hoon and Cho, Hee Sun and Han, Ji Won and Jang, Jeong Won and Choi, Jong Young and Yoon, Seung Kew and Kim, Suho and Oh, Jung Suk and Chun, Ho Jong and Sung, Pil Soo},
  title = {Higher objective responses by hepatic arterial infusion chemotherapy following atezolizumab and bevacizumab failure than when used as initial therapy in hepatocellular carcinoma: a retrospective study},
  journal = {Abdominal Radiology},
  year = {2024},
  doi = {10.1007/s00261-024-04308-6}
}
Kostenlos starten →